Your browser doesn't support javascript.
A comprehensive update of ICET-A Network on COVID-19 in thalassemias: what we know and where we stand.
De Sanctis, Vincenzo; Canatan, Duran; Corrons, Joan Lluis Vives; Karimi, Mehran; Daar, Shahina; Kattamis, Christos; Soliman, Ashraf T; Wali, Yasser; Alkindi, Salam; Huseynov, Valeh; Nasibova, Afag; Tiryaki, Tarik Onur; Sezgin Evim, Melike; Gunes, Adalet Meral; Karakas, Zeynep; Christou, Soteroula; Yassin, Mohamed A; Galati, Maria Concetta; Campisi, Saveria; Zarei, Tahereh; Khater, Doaa; Oymak, Yesim; Kaleva, Valeriya; Stoyanova, Denka; Banchev, Atanas; Skafida, Myrto; Kilinc, Yurdanur.
  • De Sanctis V; Quisisana Hospital, Ferrara. vdesanctis@libero.it.
  • Canatan D; Antalya Genetic Diseases Diagnostic Center, Antalya,Turkey. vdesanctis@libero.it.
  • Corrons JLV; Red Blood Cell and Haematopoietic Disorders Unit, Institute for Leukaemia Research Josep Carreras (IJC) and University of Barcelona, Catalonia, Spain. ENERCA Coordinator. vdesanctis@libero.it.
  • Karimi M; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. vdesanctis@libero.it.
  • Daar S; Department of Haematology, College of Medicine and Health Sciences, Sultan Qaboos University, Sultanate of Oman. vdesanctis@libero.it.
  • Kattamis C; First Department of Paediatrics, National Kapodistrian University of Athens, Athens, Greece. vdesanctis@libero.it.
  • Soliman AT; Pediatrics and Endocrinology Department of Pediatrics, Hamad Medical Center, Doha, Qatar and Department of Pediatrics, University of Alexandria, Alexandria, Egypt. vdesanctis@libero.it.
  • Wali Y; Paediatric Hematology Unit, Child Health Department, College of Medicine, Sultan Qaboos University Oman and Department of Paediatrics, Faculty of Medicine, Alexandria University, Egypt. vdesanctis@libero.it.
  • Alkindi S; Department of Haematology, College of Medicine and Health Sciences, Sultan Qaboos University, Sultanate of Oman. vdesanctis@libero.it.
  • Huseynov V; Center of Thalassemia, Baku, Azerbaijan. vdesanctis@libero.it.
  • Nasibova A; Center of Thalassemia, Baku, Azerbaijan. vdesanctis@libero.it.
  • Tiryaki TO; 10 Istanbul University, Faculty of Medicine, Department of Hematology, Istanbul,Turkey. vdesanctis@libero.it.
  • Sezgin Evim M; Uludag University, Medical Faculty, Dept. of Pediatric Hematology, Bursa, Turkey. vdesanctis@libero.it.
  • Gunes AM; Uludag University, Medical Faculty, Dept. of Pediatric Hematology, Bursa, Turkey. vdesanctis@libero.it.
  • Karakas Z; Istanbul University, Istanbul Faculty of Medicine, Pediatric Hematology / Oncology, Istanbul, Turkey. vdesanctis@libero.it.
  • Christou S; Archibishop Makarios III Hospital, Thalassaemia Clinic, Nicosia, Cyprus. vdesanctis@libero.it.
  • Yassin MA; Hematology Section, National Center for Cancer Care and Research, Hamad Medical Corporation, (HMC), Doha, Qatar. vdesanctis@libero.it.
  • Galati MC; Pediatric Haematoncology, Pugliese-Ciaccio Hospital, Catanzaro, Italy. vdesanctis@libero.it.
  • Campisi S; UOSD Thalassemia, Umberto I° Hospital, Siracusa, Italy. vdesanctis@libero.it.
  • Zarei T; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. vdesanctis@libero.it.
  • Khater D; Department of Pediatric Endocrinology Alexandria University, Egypt and Department of Pediatrics, Sultan Qaboos University, Oman, Qatar. vdesanctis@libero.it.
  • Oymak Y; Dr. Behcet Uz Children's Hospital, Izmir, Turkey. vdesanctis@libero.it.
  • Kaleva V; Expert Center for Coagulopathies and Rare Anemias, Varna, Bulgaria. vdesanctis@libero.it.
  • Stoyanova D; Pediatric Hematoncology, University Hospital "Tzaritza Giovanna - ISUL", Sofia, Bulgaria. vdesanctis@libero.it.
  • Banchev A; Pediatric Hematoncology, University Hospital "Tzaritza Giovanna - ISUL", Sofia, Bulgaria. vdesanctis@libero.it.
  • Skafida M; First Department of Paediatrics, National Kapodistrian University of Athens, Athens, Greece. vdesanctis@libero.it.
  • Kilinc Y; Pediatric Hematology Department, Çukurova University, Adana, Turkey. vdesanctis@libero.it.
Acta Biomed ; 91(3): e2020026, 2020 09 07.
Article in English | MEDLINE | ID: covidwho-761241
ABSTRACT
A review of the literature on COVID-19 pandemic in patients with thalassemias is presented. Globally, the prevalence of COVID-19 among  ß-thalassemia patients seems to be lower than in general population; associated co-morbidities aggravated the severity of  COVID- 19, leading to a poorer prognosis, irrespective of age. A multicenter registry will enhance the understanding of COVID-19 in these patients and will lead to more evidence-based management recommendations.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Thalassemia / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Acta Biomed Journal subject: Medicine Year: 2020 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Thalassemia / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Acta Biomed Journal subject: Medicine Year: 2020 Document Type: Article